Literature DB >> 3679282

Carrier-specific recognition for induction of secretory IgA anamnestic antibody responses.

J L Ebersole1, M A Taubman, D J Smith, D E Frey.   

Abstract

This study examined antigen-carrier specificity for the induction of secretory IgA antibodies in the saliva of rats. Conjugate antigens used as probes to examined the formation of SIgA antibodies included: DNP-BGG, DNP-OVA and DNP-Streptococcus mutans, as well as the unconjugated carriers BGG and OVA. The results showed that local immunization of rats with homologous hapten-carrier conjugates (i.e. DNP-BGG + DNP-BGG) resulted in secondary responses of salivary IgA and serum IgG and IgA antibodies to the hapten DNP. In contrast, heterologous conjugate (i.e. DNP-BGG + DNP-OVA) administration was unable to provide priming for anamnestic secretory or systemic responses. Priming of rats with unconjugated carrier was found to enhance the response to a local immunization with hapten-carrier antigen only in an homologous system. Also, significant carrier priming was most pronounced with serum IgG and IgA. While salivary IgA was increased somewhat following priming with unconjugated carrier, this was less than following two immunizations with the homologous hapten-carrier conjugate. These findings demonstrate carrier-specific reactions in the elicitation of secretory IgA antibodies and further support evidence of the importance of T-cell co-operation in the induction of secretory immune responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3679282      PMCID: PMC1453986     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

Review 1.  THE PATHOGENESIS OF IMMUNOLOGIC DEFICIENCY DISEASES.

Authors:  R D PETERSON; M D COOPER; R A GOOD
Journal:  Am J Med       Date:  1965-04       Impact factor: 4.965

2.  The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

3.  Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine.

Authors:  R F Buscho; J C Perkins; H L Knopf; A Z Kapikian; R M Chanock
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

4.  Role of thymus-derived lymphocytes in the secondary humoral immune response in mice.

Authors:  M C Raff
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  Secretory antibody response to local injection of soluble or particulate antigens in rats.

Authors:  D S Cox; M A Taubman; J L Ebersole; D J Smith
Journal:  Mol Immunol       Date:  1980-09       Impact factor: 4.407

6.  The induction of salivary antibodies by topical sensitization with particulate and soluble bacterial immunogens.

Authors:  J L Ebersole; J A Molinari
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

7.  Effect of neonatal thymectomy on immune responses of rats to Streptococcus mutans.

Authors:  J L Ebersole; M A Taubman; D J Smith; D E Frey
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Cellular and humoral IgA responses after single and multiple local injections of antigen.

Authors:  J L Ebersole; M A Taubman; D J Smith
Journal:  Cell Immunol       Date:  1983-04-15       Impact factor: 4.868

9.  Serum and salivary antibody responses and the development of oral tolerance after oral and intragastric antigen administration.

Authors:  J B Matthews; B H Fivaz; H F Sewell
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

10.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  1 in total

1.  Secretory immune responses to Mycoplasma pulmonis.

Authors:  M J Steffen; J L Ebersole
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.